[Weekly Compilation of Presidential Documents Volume 35, Number 10 (Monday, March 15, 1999)]
[Pages 411-412]
[Online from the Government Publishing Office, www.gpo.gov]
<R04>
Statement on Selection of the Director of the National Institutes of
Health Vaccine Research Center
March 11, 1999
I am very pleased to join Secretary of Health and Human Services
Donna Shalala, National Institutes of Health Director Harold Varmus, and
my AIDS policy office director, Sandra Thurman, in welcoming Dr. Gary
Nabel as the first Director of the new Vaccine Research Center at the
NIH. Dr. Nabel's long and distinguished career as a research scientist
will be an incredible asset in our efforts to find preventative
vaccines.
The first order of business for Dr. Nabel will be the effort to
develop a vaccine for HIV. This is a top priority of our AIDS research
efforts. Here in the United States, over 40,000 people are newly
infected with HIV every year. Across the world, the rate is nearly 6
million people per year. These are lives in jeopardy. Though we have
made remarkable progress in treating HIV and AIDS, there is still no
cure. So our best hope of bringing an end to the AIDS pandemic is to
find a safe and effective vaccine.
I have issued a challenge to the scientific community to find an
AIDS vaccine within the decade. We are making important strides towards
that critical goal and the leadership of Dr. Nabel will help us progress
even more. Dr. Varmus and his team of expert researchers at the NIH,
working in collaboration with scientists from across the globe, have
produced remarkable results in reducing AIDS mortality here and in many
other developed nations. Their improved understanding of how HIV works
will be invaluable in the effort to find a vaccine to prevent infection
in the first place.
The human tragedy of AIDS throughout the world must move all of us
to action. The search for a vaccine for HIV must continue to be a global
priority because millions of precious lives hang in the balance.
[[Page 412]]